A Prandin, GlucoNorm, NovoNorm, Repaglinide CEP of the European Pharmacopoeia monograph is often referred to as a Prandin, GlucoNorm, NovoNorm, Repaglinide Certificate of Suitability (COS). The purpose of a Prandin, GlucoNorm, NovoNorm, Repaglinide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Prandin, GlucoNorm, NovoNorm, Repaglinide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Prandin, GlucoNorm, NovoNorm, Repaglinide to their clients by showing that a Prandin, GlucoNorm, NovoNorm, Repaglinide CEP has been issued for it. The manufacturer submits a Prandin, GlucoNorm, NovoNorm, Repaglinide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Prandin, GlucoNorm, NovoNorm, Repaglinide CEP holder for the record. Additionally, the data presented in the Prandin, GlucoNorm, NovoNorm, Repaglinide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Prandin, GlucoNorm, NovoNorm, Repaglinide DMF.
A Prandin, GlucoNorm, NovoNorm, Repaglinide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Prandin, GlucoNorm, NovoNorm, Repaglinide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Prandin, GlucoNorm, NovoNorm, Repaglinide suppliers with CEP (COS) on PharmaCompass.